Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: Prevalence and diagnostic role

Digestive Diseases and Sciences

Volumn 56, Issue 6, 2011, Pages 1794-1800

  Biet, Franck ^a   Gendt, Laurent ^b   Anton, Eric ^b   Ballot, Eric ^b   Hugot, Jean Pierre ^c   Johanet, Catherine ^b,d  

^a UR1282   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Anti Mycobacterium avium subspecies paratuberculosis antibodies; Anti Saccharomyces cerevisiae antibodies; Coeliac disease; Crohn's disease

Indexed keywords

AUTOANTIBODY; BACTERIUM ANTIBODY; FUNGUS ANTIBODY; MYCOBACTERIUM PARATUBERCULOSIS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM PARATUBERCULOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 79959760768     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-010-1523-8     Document Type: Article

References (54)

1. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol. 2008;24:440-447.
2. Dalziel TK. Chronic interstitial enteritis. BMJ. 1913;2:1068-1070.
3. Chiodini RJ. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev. 1989;2:90-117. (Pubitemid 19031867)
4. Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut. 1992;33:890-896.
5. Fidler HM, Thurrell W, Johnson NM, Rook GAW, McFadden JJ. Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut. 1994;35:506-510.
6. Collins MT, Lisby G, Moser C, et al. Results of multiple diagnostic tests for Mycobacterium avium subsp paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol. 2000;38:4373-4381. (Pubitemid 32248686)
7. Wu SW, Pao CC, Chan J, Yen TS. Lack of mycobacterial DNA in Crohn's disease tissue. Lancet. 1991;337:174-175.
8. Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y. Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am J Gastroenterol. 1995;90:76-80.
9. Kanazawa K, Haga Y, Funakoshi O, Nakajima H, Munakata A, Yoshida Y. Absence of Mycobacterium paratuberculosis DNA in intestinal tissues from Crohn's disease by nested polymerase chain reaction. J Gastroenterol. 1999;34:200-206. (Pubitemid 29192559)
10. Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet. 2004;364:1039-1044. (Pubitemid 39248662)
11. Autschbach F, Eisold S, Hinz U, et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut. 2005;54:944-949. (Pubitemid 40873906)
12. Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401-410. (Pubitemid 351441331)
13. Nacy C, Buckley M. Mycobacterium avium paratuberculosis: infrequent human pathogen or public health threat? A report from the American Academy of Microbiology. http://www.asm.org/ASM/files/ccLibraryFiles/Filename/000000004169/ MAP.pdf; 2008.
14. Mendoza JL, Lana R, Diaz-Rubio M. Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol. 2009;15:417-422.
15. Carpenter TE, Gardner IA, Collins MT, Whitlock RH. Effects of prevalence and testing by enzyme-linked immunosorbent assay and fecal culture on the risk of introduction of Mycobacterium avium subsp. paratuberculosis-infected cows into dairy herds. J Vet Diagn Invest. 2004;16:31-38. (Pubitemid 38225151)
16. Green EP, Tizard ML, Moss MT, et al. Sequence and characteristics of IS900, an insertion element identified in a human Crohn's disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res. 1989;17:9063-9073. (Pubitemid 20003172)
17. Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol. 2000;14:521-539. (Pubitemid 30447224)
18. Tanaka K, Wilks M, Coates PJ, Farthing MJG, Walker-Smith JA, Tabaqchali S. Mycobacterium paratuberculosis and Crohn's disease. Gut. 1991;32:43-45.
19. Suenaga K, Yokoyama Y, Nishimori I, et al. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci. 1999;44:1202-1207. (Pubitemid 29297229)
20. Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2004;42:1129-1135. (Pubitemid 38332836)
21. Naser SA, Hulten K, Shafran I, Graham DY, El-Zaatari FA. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol. 2000;77:497-504.
22. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-791. (Pubitemid 28277217)
23. Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410-2422. (Pubitemid 44477569)
24. Desplat-Jégo S, Johanet C, Escande A, et al. Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol. 2007;13:2312-2318. (Pubitemid 46860731)
25. Koutroubakis IE, Petinaki E, Mouzas IA, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:449-454.
26. Fresko I, Ugurlu S, Ozbakir F, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome. Clin Exp Rheumatol. 2005;23:S67-S70.
27. Torok HP, Glas J, Gruber R, et al. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion. 2004;70:49-54. (Pubitemid 39179240)
28. Muratori P, Muratori L, Guidi M, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol. 2003;132:473-476. (Pubitemid 36713954)
29. Mallant-Hent RCh, Mary B, von Blomberg E, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol. 2006;18:75-78. (Pubitemid 43004885)
30. Toumi D, Mankaï A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol. 2007;42:821-826. (Pubitemid 46897632)
31. Condino AA, Hoffenberg EJ, Accurso F, et al. Frequency of ASCA seropositivity in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2005;41:23-26. (Pubitemid 40967350)
32. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; Final report on a therapeutic trial. Br Med J. 1955;2:1041-1048.
33. Malchow H, Ewe K, Brandes JW, et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249-266. (Pubitemid 14218578)
34. Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver. 1996;16:28-34.
35. Angus RD. Production of reference PPD tuberculins for veterinary use in the United States. J Biol Stand. 1978;6:221-227. (Pubitemid 9010892)
36. Kremer L, Riveau G, Baulard A, Capron A, Locht C. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. J Immunol. 1996;156:4309-4317.
37. Shafran I, Piromalli C, Decker JW, Sandoval J, Naser SA, El-Zaatari FAK. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Dig Dis Sci. 2002;47:2079-2081. (Pubitemid 35024825)
38. Muller S, Schaffer T, Schoepfer AM, Hilty A, Bodmer T, Seibold F. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. World J Gastroenterol. 2008;14:3650-3661.
39. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607-613. (Pubitemid 47268226)
40. Devlin SM, Dubinsky MC. Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD. Inflamm Bowel Dis. 2008;14:125-128. (Pubitemid 351196877)
41. Nakase H, Nishio A, Tamaki H, et al. Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn's disease. Inflamm Bowel Dis. 2006;12:62-69. (Pubitemid 43032454)
42. Van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol. 2005;5:318-330. (Pubitemid 40516157)
43. Routsias JG, Tzioufas A. The role of chaperone proteins in autoimmunity. Ann NY Acad Sci. 2006;1088:52-64. (Pubitemid 47092050)
44. Van Eden W, Wick G, Albani S, Cohen I. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann NY Acad Sci. 2007;1113:217-237. (Pubitemid 350015017)
45. Vermeire S, Rutgeerts P. Antibody responses in Crohn's disease. Gastroenterology. 2004;126:601-604. (Pubitemid 38182317)
46. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to autoand microbial antigens. Gastroenterology. 2002;123:689-699. (Pubitemid 34977074)
47. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360-367. (Pubitemid 43381681)
48. Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006;131:366-378. (Pubitemid 44142445)
49. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000;119:23-31. (Pubitemid 30452575)
50. Mpofu CM, Campbell BJ, Subramanian S, et al. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology. 2007;133:1487-1498. (Pubitemid 350029735)
51. Barreau F, Meinzer U, Chareyre F, et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. Plos One. 2007;2:e523.
52. Granito A, Muratori L, Muratori P, et al. Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut. 2006;55:296. (Pubitemid 43117295)
53. Ashorn S, Välineva T, Kaukinen K, et al. Serological responses to microbial antigens in coeliac disease patients during gluten-free diet. J Clin Immunol. 2009;29:190-195.
54. Greenstein RJ, Su L, Brown SL. Growth of M. avium subspecies paratuberculosis in culture is enhanced by nicotinic acid, nicotinamide, and alpha and beta nicotinamide adenine dinucleotide. Dig Dis Sci. 2010; Jun 29 [Epub ahead of print].